|
Magyar Pszichiátriai Társaság |
|
17th Asia Pacific Regional Conference of Alzheimer's Disease International |
Rendezvény kezdete: 2014.11.07. | Rendezvény vége: 2014.11.09. |
Helyszín: India, New Delhi, India Habitat Centre |
Dear Colleagues,
Population aging is a global phenomenon. The fastest growth of the aging population is taking place in China, India and other countries of South Asia Region.
As ageing is the single most important risk factor for dementia, the largest numbers of persons with dementia are living in this region. Out of the estimated 36 million persons living with dementia worldwide, nearly 60% live in developing countries and this figure is likely to reach 70% by 2050.
The magnitude of dementia and its impact on the institutions of society is being recognised and realised in many of these countries only recently. With increase in life expectancy and the ageing population, the problems associated with dementia will also rise.
So, while it is important to develop policies and strategies for action at national level, it is also important for countries to join hands to improve understanding and share expertise and experience.
The health systems in this region exhibit great diversity in their functioning. Only a handful of countries in this region are effectively addressing the issue of dementia with the governments recognising it as a public health issue with adequate allocation of financial and human resources. In most countries, there is little awareness on dementia, which is often assumed as a natural consequence of aging. The lack of awareness causes stigmatisation, dehumanisation, delayed diagnosis and adverse physical, economic and emotional consequence for the family and care givers.
This conference “Emerging challenges of dementia in the Asia Pacific Region” is being organised to bring together medical professionals, care providers, nursing and paramedical professionals; social and health organisations; and governmental agencies to deliberate on issues related to risk factors, preventive strategies, advocacy and policies for better facilities for diagnosis and care.
We extend a cordial invitation to all to attend the conference. We hope that we can collectively create a better environment for dementia care and bridge the gap between availability and need of resources for dementia care.
Abstract submission date has been extended till July 31, 2014.
For further information please click here. |
|
|
 |
|
Magyar Diabetes Társaság |
|
IX. Szegedi Diabétesz Nap |
Rendezvény kezdete: 2014.11.07. | Rendezvény vége: 2014.11.08. |
Szakterület(ek): Háziorvostan, Belgyógyászat, Gyermekgyógyászat, Szülészet-nőgyógyászat, Urológia, Aneszteziológia, intenzív terápia, Oxyológia, Reumatológia, Rehabilitáció, Kardiológia, Nephrologia, Neurológia, idegsebészet, Szemészet, Sebészet, Érsebészet |
Tudományos információ: Dr. Holzinger Gábor |
Munkahely neve: SZTE I.sz. Belgyógyászati Klinika |
Tel: +36/30-998 6160 |
E-mail: holzinger@t-online.hu |
Szervező: STAND-ART Ügynökség Kft. |
Munkahely neve: Horváth Judit |
Címe: 6723 Szeged, Tisza Palota B/fszt. 2.
Felső Tisza-part 31-34. |
Tel: +36 62 317 445 |
Fax: +36 62 661 331 |
E-mail: judit@stand-art.hu |
Helyszín: 6722 Szeged, Ady tér 10., SZTE József Attila TIK |
A rendezvény Web oldala: http://stand-art.hu/szdn9 |
Regisztrációs határidő: 2014. november 2. |
|
|
 |
|
Magyar Immunológiai Társaság |
|
C-HEP 2012 - 2nd World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
Rendezvény kezdete: 2012.10.18. | Rendezvény vége: 2012.10.20. |
Helyszín: Germany / Németország, Berlin, |
A rendezvény Web oldala: http://comtecmed.com/chep/2012/Default.aspx |
Dear Friends and Colleagues,
Following the success of the 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep), we are very pleased to invite you to participate in the 2nd C-Hep Congress which will be held in Berlin, Germany on October 18-20, 2012.
The large attendance and enthusiastic feedback of the 1st Congress held last May in Barcelona highlighted the need for such a meeting focusing on the needs of the busy clinician caring for HCV and HBV infected patients. The C-Hep Congress attempts to summarize all the key new data recently presented – and how it might be implemented in routine care of Hepatitis B and C patients. Overviews, state of the art lectures and controversial debates with the outstanding faculty of prominent world leaders presenting both pro and con positions challenge and explore the optimal treatment for patients, including the appropriate use of new drugs. This educational Congress focuses on clinical practices in Viral Hepatitis and benefits not only Hepatologists and Infectious Diseases specialist, but also general practitioners, internists and primary care physicians with a desire to gain knowledge in these exciting advances.
The format includes a significant allocation of time for interactive debates and questions from the audience to each panel of experts. Participants are encouraged to take an active role in the discussions with faculty members which follow each debate, in a unique and open environment.
We look forward to welcoming you at the 2nd C-Hep Congress in the lovely city of Berlin.
Sincerely,
Jürgen Rockstroh MD (Germany) and Jonathan M. Schapiro MD (Israel)
(Co-Chairpersons) |
|
|
 |
|
Magyar Immunológiai Társaság |
|
C-HEP 2012 - 2nd World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
Rendezvény kezdete: 2012.10.18. | Rendezvény vége: 2012.10.20. |
Helyszín: Germany / Németország, Berlin, |
A rendezvény Web oldala: http://comtecmed.com/chep/2012/Default.aspx |
Dear Friends and Colleagues,
Following the success of the 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep), we are very pleased to invite you to participate in the 2nd C-Hep Congress which will be held in Berlin, Germany on October 18-20, 2012.
The large attendance and enthusiastic feedback of the 1st Congress held last May in Barcelona highlighted the need for such a meeting focusing on the needs of the busy clinician caring for HCV and HBV infected patients. The C-Hep Congress attempts to summarize all the key new data recently presented – and how it might be implemented in routine care of Hepatitis B and C patients. Overviews, state of the art lectures and controversial debates with the outstanding faculty of prominent world leaders presenting both pro and con positions challenge and explore the optimal treatment for patients, including the appropriate use of new drugs. This educational Congress focuses on clinical practices in Viral Hepatitis and benefits not only Hepatologists and Infectious Diseases specialist, but also general practitioners, internists and primary care physicians with a desire to gain knowledge in these exciting advances.
The format includes a significant allocation of time for interactive debates and questions from the audience to each panel of experts. Participants are encouraged to take an active role in the discussions with faculty members which follow each debate, in a unique and open environment.
We look forward to welcoming you at the 2nd C-Hep Congress in the lovely city of Berlin.
Sincerely,
Jürgen Rockstroh MD (Germany) and Jonathan M. Schapiro MD (Israel)
(Co-Chairpersons) |
|
|
 |